Literature DB >> 25591602

End-of-life hospital care for cancer patients: an update.

Alexey Dudevich1, Allie Chen2, Cheryl Gula3, Josh Fagbemi4.   

Abstract

Cancer is the leading cause of death in Canada, and the number of new cases is expected to increase as the population ages and grows. This study examined the use of hospital services in the last month of life by adult cancer patients who died in Canadian acute care hospitals in fiscal year 2012-2013. Almost 25,000 Canadian cancer patients - excluding those in Quebec - died in acute care hospitals, representing approximately 45% of the estimated cancer deaths in 2012-2013. The proportion of in-hospital deaths varied across jurisdictions. Twenty-three percent of these patients were admitted to acute care multiple times in their last 28 days of life, with a higher percentage for rural (29%) compared to urban (21%) patients. Relatively few patients used intensive care units or received inpatient chemotherapy in their last 14 days of life.
Copyright © 2014 Longwoods Publishing.

Entities:  

Mesh:

Year:  2014        PMID: 25591602     DOI: 10.12927/hcq.2014.24025

Source DB:  PubMed          Journal:  Healthc Q        ISSN: 1710-2774


  3 in total

1.  Palliative care for cancer patients near end of life in acute-care hospitals across Canada: a look at the inpatient palliative care code.

Authors:  J Tung; J Chadder; D Dudgeon; C Louzado; J Niu; R Rahal; A Sinnarajah
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

Review 2.  The Impact of Measuring Patient-Reported Outcome Measures on Quality of and Access to Palliative Care.

Authors:  Deborah Dudgeon
Journal:  J Palliat Med       Date:  2018-01       Impact factor: 2.947

3.  Estimating National-Level Exposure to Antineoplastic Agents in the Workplace: CAREX Canada Findings and Future Research Needs.

Authors:  Amy L Hall; Paul A Demers; George Astrakianakis; Calvin Ge; Cheryl E Peters
Journal:  Ann Work Expo Health       Date:  2017-07-01       Impact factor: 2.179

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.